Close Menu

The Wall Street Journal says to expect "an uptick in acquisitions of small and midsize drug companies" but that large pharma companies are "not going on reckless shopping sprees." Bristol-Myers' Karen LaRochelle said that many in Big Pharma do have a bit of cash "and there's a lot of pressure for us to build our pipelines." Merck's Richard Kender adds that, due to the current market, deals that in the past may have been deemed "marginal" are now more likely.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.